Luisa Minghetti
From the Departments of Cell Biology and Neuroscience
Istituto Superiore di Sanità
Italy
Name/email consistency: high
- Effects of the adenosine A2A receptor antagonist SCH 58621 on cyclooxygenase-2 expression, glial activation, and brain-derived neurotrophic factor availability in a rat model of striatal neurodegeneration. Minghetti, L., Greco, A., Potenza, R.L., Pezzola, A., Blum, D., Bantubungi, K., Popoli, P. J. Neuropathol. Exp. Neurol. (2007)
- Peripheral reductive capacity is associated with cognitive performance and survival in Alzheimer's disease. Minghetti, L., Greco, A., Puopolo, M., Combrinck, M., Warden, D., Smith, A.D. J. Neuroinflammation (2006)
- Role of inflammation in neurodegenerative diseases. Minghetti, L. Curr. Opin. Neurol. (2005)
- Multiple actions of the human immunodeficiency virus type-1 Tat protein on microglial cell functions. Minghetti, L., Visentin, S., Patrizio, M., Franchini, L., Ajmone-Cat, M.A., Levi, G. Neurochem. Res. (2004)
- Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. Minghetti, L. J. Neuropathol. Exp. Neurol. (2004)
- Isoprostanes as biomarkers and mediators of oxidative injury in infant and adult central nervous system diseases. Greco, A., Minghetti, L. Current. Neurovascular. Research (2004)